Finance

Lists
Why is 300759 up 3.42%?
Dive Deeper
300759:SHE
Pharmaron Beijing Co Ltd
CN¥41.37
+3.42%
(+1.37) 1D
Oct 30, 3:04:52 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300759...
Open
CN¥39.50
High
CN¥43.53
Low
CN¥38.06
Mkt. cap
69.32B
Avg. vol.
44.02M
Volume
53.32M
Dividend
0.48%
Quarterly dividend
CN¥0.05
Ex-dividend date
Jul 7, 2026
P/E ratio
42.54
52-wk high
CN¥53.57
52-wk low
CN¥21.01
EPS
CN¥0.97
Shares outstanding
1.48B
No. of employees
27K
Open
CN¥39.50
High
CN¥43.53
Low
CN¥38.06
Mkt. cap
69.32B
Avg. vol.
44.02M
Volume
53.32M
Dividend
0.48%
Quarterly dividend
CN¥0.05
Ex-dividend date
Jul 7, 2026
P/E ratio
42.54
52-wk high
CN¥53.57
52-wk low
CN¥21.01
EPS
CN¥0.97
Shares outstanding
1.48B
No. of employees
27K
News stories
From web sources and news partners
About Pharmaron Beijing Co Ltd
CEOBoliang Lou
Employees27.3K
FoundedJul 1, 2004
Headquarters-
SectorHealth care
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
4.01B
3.58B
4.02B
4.41B
Cost of goods sold
2.57B
2.42B
2.70B
2.94B
Cost of revenue
2.57B
2.42B
2.70B
2.94B
Research and development expenses
184.42M
139.77M
156.06M
155.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
553.55M
520.12M
587.74M
589.23M
Operating expense
809.09M
701.15M
782.02M
801.27M
Total operating expenses
3.38B
3.12B
3.48B
3.74B
Operating income
629.52M
461.69M
538.28M
667.62M
Other non operating income
36.17M
-48.69M
46.54M
-191.17M
EBT including unusual items
583.78M
412.76M
513.42M
611.70M
EBT excluding unusual items
626.67M
396.21M
436.35M
565.18M
Income tax expense
94.46M
102.35M
112.13M
114.14M
Effective tax rate
16.18%
24.80%
21.84%
18.66%
Other operating expenses
34.47M
29.75M
32.75M
33.34M
Net income
522.99M
335.36M
414.83M
496.93M
Net profit margin
13.04%
9.37%
10.33%
11.27%
Earnings per share
0.33
-
-
-
Interest and investment income
9.47M
34.76M
16.83M
23.26M
Interest expense
-51.15M
-51.56M
-48.40M
-51.43M
Net interest expenses
-41.68M
-16.80M
-31.58M
-28.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
881.17M
713.34M
834.44M
919.27M
Gain or loss from assets sale
4.69M
-
-5.29M
5.29M
Upcoming events
AI content may include mistakes. Learn more
Google apps